Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Cash Flow Reinvestment Rate
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Cash Flow Reinvestment Rate of 1.33x as of September 2025, reinvesting CN¥17.49 Million (capex CN¥17.49 Million ) from operating cash flow of CN¥13.19 Million. Explore reinvestment intensity of Tianjin Tianyao Pharmaceuticals Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2000–2024)
Historical reinvestment intensity for Tianjin Tianyao Pharmaceuticals Co Ltd across 23 annual periods. Also explore Tianjin Tianyao Pharmaceuticals Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year capital reinvestment analysis for Tianjin Tianyao Pharmaceuticals Co Ltd. For live market cap and broader valuation context, see 600488 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥153.93 Million | CN¥569.37 Million | CN¥77.74 Million | ▲ +59.0% |
| 2023 | 0.17x | CN¥133.15 Million | CN¥783.01 Million | CN¥133.15 Million | ▼ -72.2% |
| 2022 | 0.61x | CN¥400.33 Million | CN¥653.52 Million | CN¥202.20 Million | ▼ -74.0% |
| 2021 | 2.36x | CN¥747.80 Million | CN¥316.89 Million | CN¥370.84 Million | ▼ -21.5% |
| 2020 | 3.01x | CN¥1.04 Billion | CN¥346.88 Million | CN¥458.51 Million | ▲ +200.2% |
| 2019 | 1.00x | CN¥279.74 Million | CN¥279.37 Million | CN¥279.04 Million | ▼ -7.0% |
| 2018 | 1.08x | CN¥203.88 Million | CN¥189.27 Million | CN¥203.58 Million | ▼ -68.2% |
| 2016 | 3.39x | CN¥214.78 Million | CN¥63.32 Million | CN¥64.78 Million | ▲ +125.9% |
| 2015 | 1.50x | CN¥194.48 Million | CN¥129.50 Million | CN¥45.32 Million | ▲ +1499.9% |
| 2014 | 0.09x | CN¥16.78 Million | CN¥178.76 Million | CN¥16.78 Million | ▼ -97.4% |
| 2013 | 3.67x | CN¥310.08 Million | CN¥84.55 Million | CN¥310.08 Million | ▼ -35.8% |
| 2012 | 5.71x | CN¥75.59 Million | CN¥13.23 Million | CN¥75.59 Million | ▲ +614.5% |
| 2011 | 0.80x | CN¥62.76 Million | CN¥78.47 Million | CN¥62.76 Million | ▼ -36.8% |
| 2010 | 1.26x | CN¥147.76 Million | CN¥116.82 Million | CN¥147.76 Million | ▲ +172.0% |
| 2009 | 0.46x | CN¥202.32 Million | CN¥435.13 Million | CN¥202.32 Million | ▼ -71.5% |
| 2008 | 1.63x | CN¥357.63 Million | CN¥219.31 Million | CN¥357.63 Million | ▲ +17.8% |
| 2007 | 1.38x | CN¥224.74 Million | CN¥162.33 Million | CN¥224.74 Million | ▼ -1.0% |
| 2006 | 1.40x | CN¥70.91 Million | CN¥50.72 Million | CN¥70.91 Million | ▲ +15.5% |
| 2004 | 1.21x | CN¥133.47 Million | CN¥110.30 Million | CN¥133.47 Million | ▼ -68.2% |
| 2003 | 3.81x | CN¥174.24 Million | CN¥45.77 Million | CN¥174.24 Million | ▲ +0.7% |
| 2002 | 3.78x | CN¥171.20 Million | CN¥45.28 Million | CN¥171.20 Million | ▲ +459.5% |
| 2001 | 0.68x | CN¥48.57 Million | CN¥71.87 Million | CN¥48.57 Million | ▼ -23.5% |
| 2000 | 0.88x | CN¥36.29 Million | CN¥41.06 Million | CN¥36.29 Million | — |